Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
10.50
+0.09 (0.86%)
Mar 31, 2025, 4:00 PM EDT - Market closed
Elanco Animal Health Revenue
In the year 2024, Elanco Animal Health had annual revenue of $4.44B with 0.50% growth. Elanco Animal Health had revenue of $1.02B in the quarter ending December 31, 2024, a decrease of -1.45%.
Revenue (ttm)
$4.44B
Revenue Growth
+0.50%
P/S Ratio
1.16
Revenue / Employee
$469,735
Employees
9,450
Market Cap
5.19B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.44B | 22.00M | 0.50% |
Dec 31, 2023 | 4.42B | 6.00M | 0.14% |
Dec 31, 2022 | 4.41B | -353.00M | -7.41% |
Dec 31, 2021 | 4.76B | 1.49B | 45.64% |
Dec 31, 2020 | 3.27B | 200.00M | 6.51% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ELAN News
- 1 day ago - Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Shareholders to Inquire about Securities Investigation - Accesswire
- 4 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Connect - Accesswire
- 6 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Stockholders to Inquire about Securities Investigation - Accesswire
- 8 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation - Accesswire
- 11 days ago - Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 13 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Connect - Accesswire
- 14 days ago - Elanco Announces Changes to Board of Directors; Signs Research Agreement to Explore Novel Therapies for Chronic Kidney Disease and Life Extension in Pets - PRNewsWire
- 18 days ago - Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire